Bank of New York Mellon’s RESPONSE GENETICS, INC COMMON SHS (DELAWARE) RGDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q3
Sell
-10,359
Closed -$4K 4472
2015
Q2
$4K Buy
+10,359
New +$3.51K ﹤0.01% 4282

Bank of New York Mellon's RGDX Position: Q3 2015 in Review

Bank of New York Mellon sold out of RESPONSE GENETICS, INC COMMON SHS (DELAWARE) (RGDX) in Q3 2015, closing a stake of 10,359 shares — an estimated $4K sold.

Bank of New York Mellon first reported a position in RGDX in Q2 2015 and held it in 1 quarter. The position peaked at $4K in Q2 2015. 1 fund tracked by Wall St. Rank holds RGDX as of Q3 2015.

  • Bank of New York Mellon reported no remaining RESPONSE GENETICS, INC COMMON SHS (DELAWARE) position as of Q3 2015 after selling out during the quarter.
  • Bank of New York Mellon sold 10,359 RESPONSE GENETICS, INC COMMON SHS (DELAWARE) shares in Q3 2015, an estimated $4K.
  • Bank of New York Mellon first reported a position in RESPONSE GENETICS, INC COMMON SHS (DELAWARE) in Q2 2015 and held it in 1 quarter.
  • Bank of New York Mellon's RESPONSE GENETICS, INC COMMON SHS (DELAWARE) position peaked at $4K in Q2 2015.
  • 1 fund tracked by Wall St. Rank held RESPONSE GENETICS, INC COMMON SHS (DELAWARE) as of Q3 2015.

Based on Bank of New York Mellon's 13F filing for Q3 2015, filed 10 Nov 2015.